Cargando…
The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs
Treatment decisions for breast cancer are based on staging and hormone receptor expression and include chemotherapies and endocrine therapy. While effective in many cases, some breast cancers are resistant to therapy, metastasize and recur, leading to eventual death. Higher percentages of tumor-init...
Autores principales: | Brown, Justin M, Wasson, Marie-Claire D, Marcato, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140662/ https://www.ncbi.nlm.nih.gov/pubmed/32244924 http://dx.doi.org/10.3390/cells9030763 |
Ejemplares similares
-
Triple-Negative Breast Cancer and the COVID-19 Pandemic: Clinical Management Perspectives and Potential Consequences of Infection
por: Brown, Justin M., et al.
Publicado: (2021) -
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer
por: Cruickshank, Brianne M., et al.
Publicado: (2021) -
Datasets exploring putative lncRNA-miRNA-mRNA axes in breast cancer cell lines
por: Wasson, Marie-Claire D, et al.
Publicado: (2021) -
Identification of novel long non-coding RNAs in triple-negative breast cancer
por: Shen, Xiaokun, et al.
Publicado: (2015) -
Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer
por: Yuan, Naijun, et al.
Publicado: (2017)